Testing effectiveness (Phase 2)UnknownNCT01737346What this trial is testingProcarbazine and Lomustine in Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma Multiforme Incheon St.Mary's Hospital 52
Large-scale testing (Phase 3)Looking for participantsNCT03970447What this trial is testingA Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaWho this might be right forGlioblastoma Global Coalition for Adaptive Research 2,250
Testing effectiveness (Phase 2)Looking for participantsNCT05432804What this trial is testingTesting the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentWho this might be right forRecurrent Glioblastoma, IDH-WildtypeRecurrent MGMT-Methylated Glioblastoma National Cancer Institute (NCI) 97
Early research (Phase 1)Ended earlyNCT02576665What this trial is testingToca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)Who this might be right forColorectal CancerTriple Negative Breast CancerPancreatic Cancer+9 more Tocagen Inc. 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03743662What this trial is testingNivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated GlioblastomaWho this might be right forGlioblastoma Memorial Sloan Kettering Cancer Center 39
Early research (Phase 1)Active Not RecruitingNCT03011671What this trial is testingStudy of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant GliomaWho this might be right forMalignant Glioma of Brain University of Chicago 10